ARQT

Arcutis Biotherapeutics, Inc. Common Stock
$21.47 +0.05%

Recent alerts on ARQT

All signals →
News Arcutis (ARQT) Stock Rises 31% in the Past Month: Here's Why - Zacks Investment Research
14d ago
News FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
14d ago
News AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
14d ago
News FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
14d ago
News OVID Slumps 76% on Epilepsy Drug Failing Two Pivotal Studies
14d ago
News Wall Street Analysts Think Arcutis Biotherapeutics (ARQT) Could Surge 99.89%: Read This Before Placing a Bet
14d ago
News Viridian (VRDN) Up 10% on Clinical Updates for Eye Disease Drug
14d ago
News Summit (SMMT) Stock Surges 57% in the Past Month: Here's Why
14d ago
News FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
14d ago
News Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
14d ago
News AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
14d ago
News Amgen's (AMGN) Uplizna Meets Study Goal for Rare Disease
14d ago
News Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study
14d ago
News Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
14d ago
News Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
14d ago
News J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
14d ago
News Iovance (IOVA) Up 5% on Updated Data From Melanoma Study
14d ago
News Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
14d ago
News Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
14d ago
News Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
14d ago
News Wall Street Analysts Believe Arcutis Biotherapeutics (ARQT) Could Rally 101.09%: Here's is How to Trade
14d ago
Insider trade Sale by Latha Vairavan (SVP Chief Financial Officer)
19d ago
Insider trade Sale by Patrick Burnett (Reporting Person's Title: EVP, Chief Medical Officer)
19d ago
News Arcutis outlines $480M-$495M 2026 revenue guidance while expanding ZORYVE sales teams
26d ago
Insider trade Sale by Masaru Matsuda (Reporting Person's title: EVP, Chief Legal Officer)
26d ago

Get push alerts for ARQT

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS